Quick Answer
MYRIAD GENETICS INC reported Long-Term Debt of $119.90 million for fiscal year 2025.
MYRIAD GENETICS INC Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $119.90M | +202.8% |
| 2024 | $39.60M | +2.9% |
| 2023 | $38.50M | — |
| 2022 | $0.00 | — |
| 2021 | $0.00 | -100.0% |
| 2020 | $224.80M | +0.2% |
| 2020 | $224.40M | -3.9% |
| 2019 | $233.50M | +2410.8% |
| 2018 | $9.30M | -90.6% |
| 2017 | $99.10M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $119.50M | +206.4% | — |
| June 30, 2025 | $0.00 | -100.0% | -100.0% |
| March 31, 2025 | $59.30M | +53.2% | +49.7% |
| December 31, 2024 | $39.60M | +2.9% | +1.5% |
| September 30, 2024 | $39.00M | +1.3% | +0.5% |
| June 30, 2024 | $38.80M | +1.0% | +0.3% |
| March 31, 2024 | $38.70M | — | +0.5% |
| December 31, 2023 | $38.50M | — | +0.0% |
- MYRIAD GENETICS INC showed an increase of +202.8% in Long-Term Debt compared to the prior fiscal year.
- Over the 2017–2025 period, MYRIAD GENETICS INC’s long-term debt has grown by 21.0% (from $99.10 million to $119.90 million).
- The most recent figure is from MYRIAD GENETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: